Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Leo Pharma AS

www.leo-pharma.com

Latest From Leo Pharma AS

China Ho! Sun Strikes Deals For Ilumya, Cequa

India's Sun has licensed out treatments for psoriasis and dry eye to a new partner for selected Asian markets and China, which it expects to emerge as a key market for its products.

China India

Novartis MAXIMISEs Cosentyx PsA Position

Up to two thirds of patients with psoriatic arthritis experience inflammatory back pain and the Swiss major has presented data showing that its best-selling drug achieved rapid and significant improvements.

Clinical Trials Companies

Thinking About Switching? Dr Gauld On The Go-To Markets Today

In this first installment of an exclusive three-part series, global switch expert Dr Natalie Gauld speaks to HBW Insight about what makes a country an attractive environment for switching and highlights those markets leading the way today. 
Health OTC Drugs

First Phase III Results Keep Pfizer's Abrocitinib Among JAK Leaders In Atopic Dermatitis

Pfizer follows Lilly as the second company to report positive top-line Phase III results in AD for a JAK inhibitor. Safety is a key concern for the class, but Pfizer did not provide any details about abrocitinib's side effects.

Clinical Trials Dermatology
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Blood & Coagulation Disorders & Products
  • Cardiovascular
  • Dermatology
  • Infectious & Viral Diseases
  • Musculoskeletal & Connective Tissue Disorders
  • Renal System
  • Respiratory, Pulmonary
  • Alias(es)
  • Leo Pharmaceutical Products Ltd.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Scandinavia
          • Denmark
  • Parent & Subsidiaries
  • Leo Pharma AS
  • Senior Management
  • Catherine Mazzacco, Pres. & CEO
    Anders Kronborg, EVP, Global Fin. & Bus. Services
    Kim Kjoller, EVP, Global R&D
  • Contact Info
  • Leo Pharma AS
    Phone: (45) 4494 5888
    55 Industriparken
    Ballerup, DK-2750
    Denmark
Advertisement
Advertisement
UsernamePublicRestriction

Register